Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide

Annals of the New York Academy of Sciences

Volumn 814, Issue , 1997, Pages 167-173

  Brenneman, Douglas E ^a   Phillips, Terry M ^b   Festoff, Barry W ^c   Gozes, Illana ^d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HEAT SHOCK PROTEIN; INTERLEUKIN 1ALPHA; LEUPEPTIN; NEUROPROTECTIVE AGENT; NEUROTROPHIC FACTOR; PROTEASE NEXIN I; SERINE PROTEINASE INHIBITOR; TETRODOTOXIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ASTROCYTE; BRAIN NERVE CELL; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; MACROGLIA; MOUSE; NERVE CELL CULTURE; NERVE INJURY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; RAT; SPINAL CORD NERVE CELL;

ANIMALIA;

EID: 0031000275     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb46155.x     Document Type: Conference Paper

References (30)

1. BRENNEMAN, D. E. & L. E. EIDEN. 1986. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. USA 83: 1159-1162.
2. GOZES, I., S. K. MCCUNE, L. JACOBSON, D. WARREN, T. W. MOODY, M. FRIDKIN & D. E. BRENNEMAN. 1991. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J. Pharmacol. Exp. Ther. 257: 959-966.
3. BRENNEMAN, D. E., E. A. NEALE, G. A. FOSTER, S. W. D'AUTREMONT & G. L. WESTBROOK. 1987. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J. Cell. Biol. 104: 1603-1610.
4. BRENNEMAN, D. E., T. NICOL, D. WARREN & L. M. BOWERS. 1990. Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25: 386-394.
5. ROBERTSON, S. A. & R. F. SEAMARK. 1992. Granulocyte-macrophage colony stimulating factor (GM-CSF): One of a family of epithelial cell-derived cytokines in the preimplantation uterus. Reprod. Fertil. Dev. 4: 435-448.
6. OTERO, G. C. & J. E. MERRILL. 1994. Cytokine receptors on glial cells. Glia 11(2): 117-128.
7. KUSHIMA, Y., T. HAMA & H. HATANAKA. 1992. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neurosci. Res. 13: 267-280.
8. RICHARDSON, P. M. 1994. Ciliary neurotrophic factor: A review. Pharmacol. Ther. 63: 187-198.
9. MORONI, S. C. & A. ROSSI. 1995. Enhanced survival and differentiation in vitro of different neuronal populations by some interleukins. Int. J. Dev. Neurosci. 13(1): 41-49.
10. BRENNEMAN, D. E., M. SCHULTZBERG, T. BARTFAI & I. GOZES. 1992. Cytokine regulation of neuronal survival. J. Neurochem. 58: 454-460.
11. BRENNEMAN, D., J. M. HILL, G. W. GLAZNER, I. GOZES & T. M. PHILLIPS. 1995. Interleukin-1 alpha and vasoactive intestinal peptide: Enigmatic regulation of neuronal survival. Int. J. Dev. Neurosci. 13: 187-200.
12. JACKSON, M. B., H. LECAR, D. E. BRENNEMAN, S. FITZGERALD & P. G. NELSON. 1982. Electrical development in spinal cord culture. J. Neurosci. 2: 1052-1061.
13. BRENNEMAN, D. E., L. E. EIDEN & R. E. SIEGEL. 1985. Neurotrophic action of VIP on spinal cord cultures. Peptides 6(Suppl. 2): 35-39.
14. MIZUGUCHI, M. & S. U. KIM. 1991. Alpha 1-antichymotrypsin supports short-term survival of cerebral neurons in culture. Neurosci. Lett. 124: 166-168.
15. POPIELA, H., T. PORTER, R. L. BEACH & B. W. FESTOFF. 1984. Peripheral nerve extract promotes long-term survival and neurite outgrowth in cultured spinal cord neurons. Cell. Mol. Neurobiol. 4: 67-77.
16. SMIRNOVA, I. V., G. J. HO, J. W. I. FENTON & B. W. FESTOFF. 1994. Extravascular proteolysis and the nervous system: Serine protease/serpin balance. Semin. Thromb. Hemostasis 20: 426-432.
17. FESTOFF, B. W., J. S. RAO & D. E. BRENNEMAN. 1990. Vascoactive intestinal polypeptide (VIP) is a secretatogue for protease nexin I (PNI) release from astrocytes. Neurosci. Abstr. 17: 909.
18. MONARD, D. D., K. STOCKEL, R. GOODMAN & H. THOENEN. 1975. Distinction between nerve growth factors and glial factors. Nature 258: 444-445.
19. FESTOFF, B. W., P. G. NELSON & D. E. BRENNEMAN. 1996. Inhibition of activity-dependent neuronal death: Vasoactive intestinal polypeptide stimulates secretion of the neurotrophic serpin. J. Neurobiol. 30: 255-266.
20. VAUGHAN, P. J., C. J. PIKE, C. W. COTMAN & D. D. CUNNINGHAM. 1994. The protease thrombin induces morphological degeneration and cell death in cultures of astrocytes and neurons. Soc. Neurosci. Abstr. 20: 641.
21. BRENNEMAN, D. E. & I. GOZES. 1992. Vasoactive intestinal peptide: A secretagogue for permissive glia-derived growth factors. Int. Soc. Dev. Neurosci. 10(Suppl. 1): 44.
22. BRENNEMAN, D. E. & I. GOZES. 1996. A femtomolar-acting neuroprotective peptide. J. Clin. Invest. 97: 2299-2307.
23. GOZES, I., G. LILLING, R. GLAZER, A. TICHER, I. E. ASHEKNAZI, A. DAVIDSON, S. RUBINRAUT, M. FRIDKIN & D. E. BRENNEMAN. 1995. Superactive lipophilic peptides discriminate multiple VIP receptors. J. Pharmacol. Exp. Ther. 273: 161-167.
24. BRENNEMAN, D. E. & I. GOZES. 1993. Prevention of gp120-associated neuronal cell death by activity-dependent neurotrophic factor. Soc. Neurosci. Abstr. 19: 659.
25. GOZES, I., A. BARDEA, A. RESHEF, R. ZAMOSTIANO, S. ZHUKOVSKY, S. RUBINRAUT, M. FRIDKIN & D. E. BRENNEMAN. 1996. Novel neuroprotective strategy for Alzheimer's disease: Inhalation of a fatty neuropeptide. Proc. Natl. Acad. Sci. USA 93: 427-432.
26. MOODY, T. W., F. ZIA, M. DRAOUI, D. E. BRENNEMAN, M. FRIDKIN, A. DAVIDSON & I. GOZES. 1993. A novel VIP antagonist inhibits non-small cell lung cancer growth. Proc. Natl. Acad. Sci. USA 90: 4345-4349.
27. BRENNEMAN, D. E., G. L. WESTBROOK, S. P. FITZGERALD, D. L. ENNIST, K. L. ELKINS, M. R. RUFF & C. B. PERT. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639-642.
28. MOODY, T. W., F. ZIA, A. L. GOLDSTEIN, P. H. NAYLOR, E. SARIN, D. E. BRENNEMAN, A. M. C. KOROS, J. C. REUBI, L. Y. KORMAN, M. FRIDKIN & I. GOZES. 1992. VIP analogues inhibit small cell lung cancer growth. Biomedical Res. 13(Suppl. 2): 131-135.
29. LILLING, G., Y. WOLLMAN, M. N. GOLDSTEIN, S. RUBINRAUT, M. FRIDKIN, D. E. BRENNEMAN & I. GOZES. 1995. Inhibition of human neuroblastoma growth by a specific VIP antagonist. J. Mol. Neurosci. 5: 231-239.
30. PHILLIPS, T. M. & P. I. KIMMELL. 1994. High-performance capillary electrophoretic analysis of inflammatory cytokines in human biopsies. J. Chromatogr. 656: 259-266.